No Reduction Compared to Closed Reduction for Distal Radius Fractures in Patients Over 65 or Older

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65+
SponsorTampere University Hospital

About this trial

DISCLOSE trial is a randomized controlled trial including 532 participants with low-energy distal radius fractures. The primary objective is to evaluate whether casting without prior closed reduction is equivalent to casting following closed reduction with respect to wrist-related pain and disability, as measured by the Patient-Rated Wrist Evaluation (PRWE) score at 12 months, in patients aged 65 years or older with a displaced distal radius fracture.

* Primary endpoint will be PRWE at 12 months * Follow-up visits are scheduled at 3 and 12 months. 5-year follow-up will be considered as an exploratory endpoint

Eligibility criteria

Qualifiers

Age 65 years or older

Independent living patients

Displaced distal radius fracture (AO/OTA 23A/23C) with 15-40 degree dorsal angulation, and/or of shortening of the radius for more than 2 mm.

Associated ulnar styloid fracture is permitted

Disqualifiers

Patient unable to provide consent

Patients who are actively working in a paid position

Volar angulation, partial articular fractures (AO/OTA 23B)

Concomitant fracture of the ulna proximal to the base of the styloid process

Trial design

Treatments tested in this trial

  • No reduction
  • Closed Reduction
  • Casting

Treatment groups

532 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Tampere University Hospital

Lead sponsor

Kuopio University Hospital

Collaborator

Viborg Regional Hospital

Collaborator

Karolinska University Hospital

Collaborator

Helsinki University Central Hospital

Collaborator

Tartu University Hospital

Collaborator

Pori Central Hospital

Collaborator

Oulu University Hospital

Collaborator